EUVIMEDOntdek EUVIMED
Crossref

High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients

Annabelle de St Maurice, G Ng, C Aryasomayajula, A Liman, S V McDiarmid, R S Venick, Laura J Wozniak

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15035 ↗

At a glance

Journal article in Clinical Transplantation, 2023. Written by Annabelle de St Maurice and 6 co-authors. Institution: Department of Pediatrics, Division of Pediatric Infectious Diseases, Mattel Children's Hospital, University of California Los Angeles, Los Angeles, C…. Major MEDLINE topics: Hepatitis A, Liver Transplantation, Hepatitis B. Cited 3 times so far (Crossref); 22 references.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Background

Pediatric liver transplant recipients are at increased risk of post‐transplant infections. The purpose of this study was to quantify hepatitis A and B non‐immunity based on antibody titers in liver transplant recipients.

Methods

We conducted a retrospective chart review of 107 pediatric liver transplant recipients at a single medical center from 2000 to 2017. We compared hepatitis immune patients to non‐immune patients and studied response to vaccination in patients immunized post‐transplantation.

Results

Eighty‐one percent of patients had pre‐transplant immunity to hepatitis A whereas 68% had pre‐transplant immunity to hepatitis B. Post‐transplant hepatitis B immunity decreased to 33% whereas post‐transplant hepatitis A immunity remained high at 82%. Older age and time since transplantation were significantly associated with hepatitis B non‐immunity. Most patients responded to doses post‐transplantation with 78% seroconversion following hepatitis A re‐immunization and 83% seroconversion following hepatitis B re‐immunization.

Conclusions

Pediatric liver transplant recipients are at risk of hepatitis A and B non‐immunity, particularly with respect to hepatitis B. Boosters post‐transplant may improve immunity to hepatitis viruses.

Subjects

MeSH terms (MEDLINE)

Hepatitis ALiver TransplantationHepatitis BHumansChildPrevalenceRetrospective StudiesTransplant RecipientsHepatitis B Vaccines

Author keywords

hepatitisimmunityliver transplantpediatric immunizations

Substances

Hepatitis B Vaccines

Authors and institutions

  • Department of Pediatrics, Division of Pediatric Infectious Diseases, Mattel Children's Hospital, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Pediatrics and Internal Medicine, University of Rochester, Rochester, New York, USA.
  • Department of Obstetrics and Gynecology, Santa Clara Homestead Medical Center, Kaiser Permanente, Santa Clara, USA.
  • Division of Pediatric Gastroenterology, Department of Pediatrics, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California, USA.
  • Department of Pediatrics, Division of Pediatric Gastroenterology, Mattel Children's Hospital, University of California Los Angeles, Los Angeles, California, USA.
  • Pediatric Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, California, USA.

Cite

APA

de St Maurice, A., Ng, G., Aryasomayajula, C., Liman, A., McDiarmid, S. V., Venick, R. S., & Wozniak, L. J. (2023). High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.15035

Vancouver

de St Maurice A, Ng G, Aryasomayajula C, Liman A, McDiarmid SV, Venick RS, et al. High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients. Clinical Transplantation. 2023. doi:10.1111/ctr.15035

BibTeX
@article{deStMaurice2023,
  author = {de St Maurice, Annabelle and Ng, G and Aryasomayajula, C and Liman, A and McDiarmid, S V and Venick, R S and Wozniak, Laura J},
  title = {High prevalence of hepatitis A and B nonimmunity in pediatric liver transplant recipients},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15035}
}
Start for free →